Study identification

EU PAS number

EUPAS8517

Study ID

30783

Official title and acronym

Validation of a US Health Care Claims Database for the Study of Cardiovascular and Neoplasm Events among Users of Treatments for Overactive Bladder

DARWIN EU® study

No

Study countries

United States

Study status

Finalised
Research institutions and networks

Institutions

Contact details

Brandon Suehs

Primary lead investigator

Study timelines

Date when funding contract was signed

Actual:

Study start date

Actual:

Date of final study report

Planned:
Actual:
Sources of funding
Pharmaceutical company and other private sector 

More details on funding

Astellas Pharma Global Development
Regulatory

Was the study required by a regulatory body?

Yes

Is the study required by a Risk Management Plan (RMP)?

EU RMP category 3 (required)